Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab (Q40550086)
Jump to navigation
Jump to search
scientific article published on June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab |
scientific article published on June 2004 |
Statements
1 reference
Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab (English)
1 reference
Judith E Karp
1 reference
Ivana Gojo
1 reference
Roberto Pili
1 reference
Christopher D Gocke
1 reference
Jacqueline Greer
1 reference
Chuanfa Guo
1 reference
David Qian
1 reference
Lawrence Morris
1 reference
Michael Tidwell
1 reference
Helen Chen
1 reference
James Zwiebel
1 reference
1 June 2004
1 reference
1 reference
Identifiers
1 reference